FDA Inspection
Conopco Inc. d/b/a UnileverConopco Inc. d/b/a Unilever – FDA Inspection, Jul 13, 2026
Record Details
This FDA Inspection record concerns Conopco Inc. d/b/a Unilever, with an inspection on July 13, 2026, issued by the Atlanta District Office, covering human drugs.
View Company Profile
ID · 07417907-a7f0-4218-af73-c15a1890d659
Inspection Facts
- Inspection number
- 1326098
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.170(b)Annual visual exams of drug products
- 21 CFR 211.182Written records kept in individual logs
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.67(b)Written procedures not established/followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Conopco Inc. d/b/a Unilever
2| Date | Classification | Office | Project area |
|---|---|---|---|
| May 27, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 16, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Conopco Inc. d/b/a Unilever
- FDA Inspection 1172861 - 2022-05-27
- FDA Inspection 989403 - 2016-09-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.